Literature DB >> 19914077

Novel 4-thiazolidinone derivatives as potential antifungal and antibacterial drugs.

Kouatli Omar1, Athina Geronikaki, Panagiotis Zoumpoulakis, Charalabos Camoutsis, Marina Soković, Ana Cirić, Jasmina Glamoclija.   

Abstract

As part of ongoing studies in developing new antimicrobials, a class of structurally novel 4-thiazolidinone derivatives incorporating three known bioactive nuclei such as thiazole, thiazolidinone and adamantane was synthesized by the multi-step reaction protocol, already reported in the literature. NMR and Molecular Modeling techniques were employed for structure elucidation and Z/E potential isomerism configuration of the analogues. Evaluation of antibacterial and antifungal activity showed that almost all compounds exhibited better results than reference drugs thus they could be promising candidates for novel drugs. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19914077     DOI: 10.1016/j.bmc.2009.10.041

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  24 in total

1.  Palladium-catalyzed acid-free Fujiwara-Moritani alkenylation of 4-thiazolidinones.

Authors:  Anuj Patel; Janki Patel; Kishor H Chikhalia
Journal:  Mol Divers       Date:  2017-06-15       Impact factor: 2.943

2.  Antimicrobial activity and cytotoxicity of some 2-amino-5-alkylidene-thiazol-4-ones.

Authors:  Marko Jukič; Aleksandra Đorđević; Jelena Lazarević; Martina Gobec; Andrija Šmelcerović; Marko Anderluh
Journal:  Mol Divers       Date:  2013-09-06       Impact factor: 2.943

3.  Antibacterial evaluation and molecular docking studies of pyrazole-thiosemicarbazones and their pyrazole-thiazolidinone conjugates.

Authors:  Oluwakemi Ebenezer; Ashona Singh-Pillay; Neil A Koorbanally; Parvesh Singh
Journal:  Mol Divers       Date:  2020-02-21       Impact factor: 2.943

4.  Synthesis and Aldose Reductase Inhibitory Effect of Some New Hydrazinecarbothioamides and 4-Thiazolidinones Bearing an Imidazo[2,1-b]Thiazole Moiety.

Authors:  Nuray Ulusoy Güzeldemirci; Selin Cimok; Net Daş-Evcimen; Mutlu Sarikaya
Journal:  Turk J Pharm Sci       Date:  2018-12-31

5.  Organocatalysis in heterocyclic synthesis: DABCO as a mild and efficient catalytic system for the synthesis of a novel class of quinazoline, thiazolo [3,2-a]quinazoline and thiazolo[2,3-b] quinazoline derivatives.

Authors:  Haider Behbehani; Hamada Mohamed Ibrahim
Journal:  Chem Cent J       Date:  2013-05-07       Impact factor: 4.215

6.  Design, synthesis and antimicrobial evaluation of novel 2-aryl-thiazolidin-4-one derivatives.

Authors:  Davinder Prasad; Awanit Kumar; Praveen Kumar Shukla; Mahendra Nath
Journal:  Org Med Chem Lett       Date:  2011-08-03

7.  Dimethyl (2Z)-2-[4-((1Z)-1-{2-[(2Z,5Z)-5-(2-meth-oxy-2-oxo-ethyl-idene)-4-oxo-3-phenyl-1,3-thia-zolidin-2-yl-idene]hydra-zin-1-yl-idene}eth-yl)anilino]but-2-ene-dio-ate.

Authors:  Shaaban K Mohamed; Mehmet Akkurt; Joel T Mague; Alaa A Hassan; Mustafa R Albayati
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-11-30

8.  Synthesis, characterization and biological evaluation of Pd(ii), Cu(ii), Re(i) and 99mTc(i) thiazole-based complexes.

Authors:  Jelena M Mašković; Antonios Hatzidimitriou; Ana Damjanović; Tatjana P Stanojković; Srećko R Trifunović; Athina A Geronikaki; Dionysia Papagiannopoulou
Journal:  Medchemcomm       Date:  2018-04-13       Impact factor: 3.597

9.  2-Heteroarylimino-5-arylidene-4-thiazolidinones as a new class of non-nucleoside inhibitors of HCV NS5B polymerase.

Authors:  Ilkay Küçükgüzel; Gökhan Satılmış; K R Gurukumar; Amartya Basu; Esra Tatar; Daniel B Nichols; Tanaji T Talele; Neerja Kaushik-Basu
Journal:  Eur J Med Chem       Date:  2013-09-12       Impact factor: 6.514

10.  Synthesis, Antimicrobial and cytotoxic activity of New Heterocyclic Hybrids Based on 2,5-Dimethylpyrrole and Pyrrole Scaffolds.

Authors:  S D Joshi; U A More; V H Kulkarni
Journal:  Indian J Pharm Sci       Date:  2013-05       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.